Pharmacists – Required Notification and Authorized Substitution – Lower-Costing Drugs, Medical Devices, and Biological Products. Requiring a pharmacist or a pharmacist’s designee who is under certain supervision to inform a certain consumer of the availability of certain therapeutically equivalent drugs, substantially equivalent medical devices, or interchangeable biological products and the cost difference between those drugs, devices, or products and certain prescribed drugs, medical devices, or biological products; etc.